Cramer now sees value in drug stock Valeant after its CEO 'delivered'

In this video

Share

Cramer now sees value in drug stock Valeant after its CEO 'delivered'

CNBC's Jim Cramer discusses his take on Valeant shares.
01:46
Wed, Jun 6 201811:37 AM EDT